$BNAI
Brand Engagement Network Inc.

2021 Q1 Form 10-Q Financial Statement

#000119312521220626 Filed on July 21, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2020 Q4 2020
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $160.0K $10.00K
YoY Change
Operating Profit -$160.0K
YoY Change
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net -$1.244M
YoY Change
Pretax Income -$1.404M -$10.00K
YoY Change
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$1.404M -$10.00K
YoY Change
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$35.48K -$310.70
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2021 Q1 2020 Q4 2020
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.574M
YoY Change
Cash & Equivalents $1.574M
Short-Term Investments
Other Short-Term Assets $872.4K $70.00K
YoY Change
Inventory
Prepaid Expenses $872.4K
Receivables
Other Receivables
Total Short-Term Assets $2.446M $70.00K
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $309.5M
YoY Change
Total Long-Term Assets $309.5M $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $2.446M $70.00K
Total Long-Term Assets $309.5M $0.00
Total Assets $311.9M $71.55K $70.00K
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $50.74K $40.00K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $10.00K
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $67.74K $51.55K $50.00K
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $27.77M
YoY Change
Total Long-Term Liabilities $27.77M $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $67.74K $51.55K $50.00K
Total Long-Term Liabilities $27.77M $0.00
Total Liabilities $26.83M $51.55K $50.00K
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$591.3K -$5.000K
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$25.39M $20.00K $20.00K
YoY Change
Total Liabilities & Shareholders Equity $311.9M $71.55K $70.00K
YoY Change

Cashflow Statement

Concept 2021 Q1 2020 Q4 2020
OPERATING ACTIVITIES
Net Income -$1.404M -$10.00K
YoY Change
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$954.9K $0.00
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$309.5M
YoY Change
Cash From Investing Activities -$309.5M
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $303.3M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 312.0M
YoY Change
NET CHANGE
Cash From Operating Activities -954.9K 0.000
Cash From Investing Activities -309.5M
Cash From Financing Activities 312.0M
Net Change In Cash 1.574M 0.000
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$954.9K $0.00
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q4 us-gaap Assets
Assets
71546
CY2021Q1 us-gaap Cash
Cash
1573788
CY2021Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
872378
CY2021Q1 us-gaap Assets Current
AssetsCurrent
2446166
CY2020Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
71546
CY2021Q1 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
309450720
CY2021Q1 us-gaap Assets
Assets
311896886
CY2021Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
50738
CY2021Q1 dhcau Accrued Offering Expenses Current
AccruedOfferingExpensesCurrent
17000
CY2020Q4 dhcau Accrued Offering Expenses Current
AccruedOfferingExpensesCurrent
37905
CY2020Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
13641
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
67738
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
51546
CY2021Q1 dhcau Warrant Liabilities Non Current
WarrantLiabilitiesNonCurrent
16934265
CY2020Q4 dhcau Warrant Liabilities Non Current
WarrantLiabilitiesNonCurrent
0
CY2021Q1 dhcau Deferred Underwriting Fee Payable
DeferredUnderwritingFeePayable
10830775
CY2020Q4 dhcau Deferred Underwriting Fee Payable
DeferredUnderwritingFeePayable
0
CY2021Q1 us-gaap Liabilities
Liabilities
27832778
CY2020Q4 us-gaap Liabilities
Liabilities
51546
CY2021Q1 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
279064100
CY2021Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
6407837
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
24137
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1408996
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-5000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
5000008
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
20000
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
311896886
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
71546
CY2021Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q1 dhcau Operating And Formation Costs
OperatingAndFormationCosts
160016
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-160016
CY2021Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
657641
CY2021Q1 dhcau Transaction Costs Allocated To Warrant Liabilities
TransactionCostsAllocatedToWarrantLiabilities
586339
CY2021Q1 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
1243980
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-1403996
CY2021Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2021Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
282314582
CY2021Q1 dhcau Cash Paid In Excess Of Fair Value For Private Warrants
CashPaidInExcessOfFairValueForPrivateWarrants
3133522
CY2021Q1 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
-279064100
CY2021Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
1573788
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1573788
CY2021Q1 dhcau Offering Costs Included In Accrued Offering Costs
OfferingCostsIncludedInAccruedOfferingCosts
17000
CY2021Q1 dhcau Offering Costs Paid Through Promissory Note
OfferingCostsPaidThroughPromissoryNote
130916
CY2021Q1 dhcau Payment Of Prepaid Expenses Through Promissory Note
PaymentOfPrepaidExpensesThroughPromissoryNote
26800
CY2021Q1 dhcau Initail Classification Of Ordinary Shares Subject To Possible Redemption
InitailClassificationOfOrdinarySharesSubjectToPossibleRedemption
271198440
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-1403996
CY2021Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
657641
CY2021Q1 dhcau Transaction Costs Allocated To Warrant Liabilities
TransactionCostsAllocatedToWarrantLiabilities
586339
CY2021Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
845578
CY2021Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
50738
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-954856
CY2021Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
309450720
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-309450720
CY2021Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
303261706
CY2021Q1 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
9189015
CY2021Q1 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
171357
CY2021Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
300000
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
311979364
CY2021Q1 dhcau Change In Value Of Class A Ordinary Shares Subject To Redemption
ChangeInValueOfClassAOrdinarySharesSubjectToRedemption
7865660
CY2021Q1 dhcau Deferred Underwriting Fees Payable
DeferredUnderwritingFeesPayable
10830775
CY2021Q1 dhcau Forfeiture Of Founder Shares
ForfeitureOfFounderShares
-89
CY2020Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
0
CY2021Q1 dei Document Type
DocumentType
10-Q
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021Q1 dei Amendment Flag
AmendmentFlag
false
CY2021Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2021Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2021Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2021Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001838163
CY2021Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2021Q1 dei Entity Shell Company
EntityShellCompany
true
CY2021Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2021Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2021Q1 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2021Q1 dhcau Percentage Of Outstanding Shares Accepted By Holders To Receive Cash
PercentageOfOutstandingSharesAcceptedByHoldersToReceiveCash
0.50
CY2021Q1 dhcau Warrant Liabilities Non Current
WarrantLiabilitiesNonCurrent
15840000
CY2021Q1 us-gaap Liabilities
Liabilities
26828357
CY2021Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
5590191
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-591339
CY2021Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Use of Estimates </div></div></div></div> <div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The preparation of the unaudited condensed financial statements in conformity with GAAP requires the Company&#8217;s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. </div></div> <div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these financial statements is the determination of the fair value of the warrant liability. Accordingly, the actual results could differ significantly from those estimates. </div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2021Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Concentration of Credit Risk </div></div></div></div> <div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times may exceed the Federal Depository Insurance Corporation coverage limit of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such account. </div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2021Q1 dhcau Number Of Days After The Completion Of The Business Combination Termination Of The Applicable Lockup Period Occurs
NumberOfDaysAfterTheCompletionOfTheBusinessCombinationTerminationOfTheApplicableLockupPeriodOccurs
P30D
CY2021Q1 dhcau Deferred Underwriting Fee Payable Per Unit
DeferredUnderwritingFeePayablePerUnit
0.35
CY2021Q1 dhcau Deferred Underwriting Fee Payable Non Current
DeferredUnderwritingFeePayableNonCurrent
10830775
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3038662
CY2021Q1 dhcau Number Of Days After Consummation Of Business Combination Within Which Securities Shall Be Registered With Securities Exchange Commission
NumberOfDaysAfterConsummationOfBusinessCombinationWithinWhichSecuritiesShallBeRegisteredWithSecuritiesExchangeCommission
P20D
CY2021Q1 dhcau Number Of Days After Consummation Of Business Combination Within Which Securities Registration Shall Become Effective
NumberOfDaysAfterConsummationOfBusinessCombinationWithinWhichSecuritiesRegistrationShallBecomeEffective
P60D
CY2021Q1 dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2020-12-22
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
300000000
CY2021Q1 us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
9450720
CY2021Q1 dhcau Transaction Cost
TransactionCost
17501346
CY2021Q1 dhcau Cash Underwriting Fee Payable
CashUnderwritingFeePayable
6189014
CY2021Q1 dhcau Other Offering Costs Payable
OtherOfferingCostsPayable
481557
CY2021Q1 dhcau Percentage Of Asset Held In Trust Account
PercentageOfAssetHeldInTrustAccount
0.80
CY2021Q1 us-gaap Business Acquisition Percentage Of Voting Interests Acquired
BusinessAcquisitionPercentageOfVotingInterestsAcquired
0.50
CY2021Q1 dhcau Number Of Days Related To Payment To Acquire Restricted Investment
NumberOfDaysRelatedToPaymentToAcquireRestrictedInvestment
P2D
CY2021Q1 dhcau Net Tangible Assets Required For Consummation Of Business Combination
NetTangibleAssetsRequiredForConsummationOfBusinessCombination
5000001
CY2021Q1 dhcau Number Of Months Determining Public Shares Redemption
NumberOfMonthsDeterminingPublicSharesRedemption
P24M
CY2021Q1 dhcau Number Of Months Related To Consummation Of Business Combination
NumberOfMonthsRelatedToConsummationOfBusinessCombination
P24M
CY2021Q1 dhcau Number Of Days For Consummation Of Business Combination
NumberOfDaysForConsummationOfBusinessCombination
P10D
CY2021Q1 dhcau Dissolution Expenses
DissolutionExpenses
100000
CY2021Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
0
CY2021Q1 us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
0
CY2021Q1 dhcau Term Of Short Term Investments
TermOfShortTermInvestments
P3M
CY2021Q1 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2020Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
16915007
CY2021Q1 dhcau Offering Costs Allocated To Warrant Liabilities Charged To Income Statement
OfferingCostsAllocatedToWarrantLiabilitiesChargedToIncomeStatement
586339
CY2021Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2021Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2020Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2021Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
CY2021Q1 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2021Q1 dei Entity Registrant Name
EntityRegistrantName
DHC Acquisition Corp.
CY2021Q1 dhcau Future Confirming Events
FutureConfirmingEvents
one or more future confirming events
CY2021Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2021Q1 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
3554928
CY2021Q1 dei Entity File Number
EntityFileNumber
001-40130
CY2021Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
E9
CY2021Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
535 Silicon Drive
CY2021Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 100
CY2021Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Southlake
CY2021Q1 dei City Area Code
CityAreaCode
214
CY2021Q1 dei Local Phone Number
LocalPhoneNumber
452-2300
CY2021Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-1574798

Files In Submission

Name View Source Status
0001193125-21-220626-index-headers.html Edgar Link pending
0001193125-21-220626-index.html Edgar Link pending
0001193125-21-220626.txt Edgar Link pending
0001193125-21-220626-xbrl.zip Edgar Link pending
d467743d10q.htm Edgar Link pending
d467743dex311.htm Edgar Link pending
d467743dex312.htm Edgar Link pending
d467743dex321.htm Edgar Link pending
d467743dex322.htm Edgar Link pending
dhcau-20210331.xml Edgar Link completed
dhcau-20210331.xsd Edgar Link pending
dhcau-20210331_cal.xml Edgar Link unprocessable
dhcau-20210331_def.xml Edgar Link unprocessable
dhcau-20210331_lab.xml Edgar Link unprocessable
dhcau-20210331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending